DiaMedica Therapeutics
DMAC
DMAC
45 hedge funds and large institutions have $36.5M invested in DiaMedica Therapeutics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.
Holders
45
Holders Change
+5
Holders Change %
+12.5%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
16
Reduced
5
Closed
5
Calls
$264K
Puts
$6K
Net Calls
+$258K
Net Calls Change
+$65K
Top Buyers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$2.04M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$6.74M |
| 3 |
CLG
3
Cooperman Leon G
|
$8.82M |
| 4 |
6CM
4
683 Capital Management
New York
|
$413K |
| 5 |
5
Goldman Sachs
New York
|
$374K |
